Continuous Downstream Processing Skid Engineering for Biopharmaceuticals

Our continuous downstream processing skid engineering delivers integrated, GMP-aligned modular purification systems designed to replace traditional batch DSP workflows for monoclonal antibodies, recombinant proteins, viral vectors and vaccine drug substances. This end-to-end service addresses core biomanufacturing bottlenecks: low resin utilization, excessive buffer consumption, large intermediate hold volumes, extended processing durations, batch-to-batch variability and fragmented multi-vendor integration. Built in compliance with ASME BPE, EU GMP Annex 1, FDA 21 CFR Part 211 and PIC/S guidelines, our scope spans process modelling, unit operation sequencing, hygienic skid design, chromatography and TFF module integration, PAT instrumentation deployment, FAT/SAT execution, site commissioning and full IQ/OQ/PQ validation packages. Suitable for greenfield biomanufacturing campuses and brownfield production line retrofits, we enable biotech firms, CDMOs and pharma owners to transition from discrete batch purification to steady-state continuous bioprocessing.

Developed on continuous-process intensification and hygienic-by-design principles, our skid architecture orchestrates sequential unit operations including multi-column continuous capture, polishing chromatography, inline viral inactivation, single-pass TFF concentration and diafiltration, and final filtration. The skid accommodates stainless steel or single-use flow paths, with ASME BPE-compliant orbital welding, minimized dead-leg geometry, sanitary valve manifolds and integrated buffer management modules. Real-time PAT sensors monitor critical quality attributes and CPPs across the uninterrupted workflow, feeding data to a GAMP 5 control system with secure batch recording, audit trails and seamless connectivity to plant SCADA and LIMS platforms. Digital twin simulation validates fluid dynamics, residence time distribution and pressure profiles before fabrication, ensuring stable steady-state operation. Modular unit layouts support flexible reconfiguration for diverse biologic modalities and scalable throughput expansion.

Compared with conventional field-assembled batch downstream lines, our continuous DSP skid engineering delivers measurable improvements in productivity, yield and operational economy. Continuous multi-column chromatography maximizes resin loading capacity, cutting resin expenditure while elevating product recovery. Inline processing eliminates large intermediate hold tanks, reducing cleanroom footprint and lowering buffer and water consumption. Factory assembly, calibration and full FAT testing in controlled workshop environments reduce on-site installation risk and shorten validation timelines. Complete documentation packages including material traceability, weld records, sensor calibration and process risk assessments streamline regulatory inspections. The closed automated workflow reduces manual intervention and contamination hazards, stabilizes product quality, and supports flexible campaign switching for multi-product biomanufacturing facilities.

Our continuous downstream processing skid solutions represent the foundational infrastructure for next-generation intensified biomanufacturing. Deployed for clinical and commercial production of therapeutic antibodies, viral vectors, recombinant proteins and vaccine drug substances, the platform empowers biopharma operators to unlock the full value of continuous bioprocessing. By embedding process science, hygienic mechanical design and regulatory compliance into unified skid delivery, we mitigate technology transfer risks and accelerate time-to-market for biologic candidates. Reduced consumable usage, smaller facility footprint and higher product throughput drive down total cost of goods. This enables biopharma enterprises and CDMOs to build agile, resilient and future-ready purification capacity within the rapidly evolving global biotherapeutic supply ecosystem.